Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)

New England Journal of Medicine

Volumn 324, Issue 20, 1991, Pages 1385-1393

  Warrell, Raymond P ^a   Frankel, Stanley R ^a   Miller, Wilson H ^a   Scheinberg, David A ^a   Itri, Loretta M ^a   Hittelman, Walter N ^b   Vyas, Rohini ^b   Andreeff, Michael ^a   Tafuri, Agostino ^a   Jakubowski, Ann ^a   Gabrilove, Janice ^a   Gordon, Michael S ^a   Dmitrovsky, Ethan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MARKER; RECEPTOR; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CELL MATURATION; CHROMOSOME 17; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; KARYOTYPE; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; CARRIER PROTEINS; CHILD; CHROMOSOME ABERRATIONS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOBLOTTING; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGE; NEOPLASM PROTEINS; RECEPTORS, RETINOIC ACID; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRETINOIN;

EID: 0025882306     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199105163242002     Document Type: Article

References (48)

1. Groopman J, Ellman L. Acute promyelocytic leukemia. Am J Hematol 1979; 7: 395–408.
2. Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM, Rowley JD. Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia. Am J Med 1984; 76: 827–41.
3. Lemons RS, Eilender D, Waldmann RA, et al. Cloning and characterization of the t( 15; 17) translocation breakpoint region in acute promyelocytic leukemia. Genes Chromosom Cancer 1990; 2: 79–87.
4. Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–80.
5. de The H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(l5;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558–61.
6. Miller WH Jr, Warrell RPJr, Frankel SR.et al. Novel retinoic acid receptoralpha transcripts in acute promyelocytic leukemia responsive to all-transretinoic acid. J Natl Cancer Inst 1990; 82: 1932–3.
7. Chomienne C, Ballerini P, Balitrand N, et al. The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia 1990; 4: 802–7.
8. Longo L, Pandolfi PP, Biondi A, et al. Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. J Exp Med 1990; 172: 1571–5.
9. Collins SJ, Robertson KA, Mueller L. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol Cell Biol 1990; 10: 2154–63.
10. Huang ME, Ye YC, Chai JR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–72.
11. Castaigne S, Chomienne C, Daniel MT, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–9.
12. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the FrenchAmerican-British Cooperative Group. Ann Intern Med 1985: 103:620–5.
13. Mohamed AN, Clarkson BD, Chaganti RSK. High resolution banding of chronic myeloid leukemia chromosomes. Cancer Genet Cytogenet 1986; 20: 209–22.
14. Cheson BD, Cassileth PA, Head DR. et al. Report on the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813–9.
15. Scheinberg DA, Tanimoto M, McKenzie S, Strife A, Old LJ, Clarkson BD. Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia. Leukemia 1989; 3: 440–5.
16. Terstappen LWM. Safford M, Loken MR. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia 1990; 4: 657–63.
17. Andreeff M, DarzynkiewiczZ, SharplessTK, Clarkson BD, Melamed MR. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 1980; 55: 282–93.
18. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–9.
19. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444–50.
20. Dmitrovsky E, Murty VVVS, Moy D, et al. Isochromosome 12p in nonseminoma cell lines: karyologic amplification of c-ki-ras2 without pointmutational activation. Oncogene 1990; 5: 543–8.
21. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503–17.
22. English D, Andersen BR. Single-step separation of red blood cells: granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll–Hypaque. J Immunol Methods 1974; 5: 249–52.
23. Hittelman WN, Agbor P, Petkovic I, et al. Detection of leukemic clone maturation in vivo by premature chromosome condensation. Blood 1988; 72: 1950–60.
24. Hittelman WN, Petkovic I, Agbor P. Improvements in the premature chromosome condensation technique for cytogenetic analysis. Cancer Genet Cytogenet 1988; 30: 301–12.
25. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Nati Acad Sci U S A 1986; 83: 2934–8.
26. Muindi J, Frankel S, Young CW, Warrell RP Jr. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Proc Am Soc Clin Oncol (in press).
27. Chomienne C, Ballerini P, Balitrand N, et al. Retinoic acid therapy for promyelocytic leukaemia. Lancet 1989; 2: 746–7.
28. Chomienne C, Ballerini P, Balitrand N, et al. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood 1990; 76: 1710–7.
29. Andreeff M, Redner A, Thongprassert S, Eagle B, et al. Multiparameter flow cytometry for determination of ploidy, proliferation, and differentiation in acute leukemia: treatment effects and prognostic value. In: Buchner T, ed. Tumor aneuploidy. Berlin, Germany: Springer-Verlag, 1985:81–105.
30. Kantarjian HM, Keating MJ, McCredie KB, et al. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia. J Clin Oncol 1985; 3: 793–8.
31. Wallace PJ. Complete remission in acute promyelocytic leukemia despite persistence of the 15;17 translocation. Am J Hematol 1989; 31: 266–8.
32. Stone RM, Maguire M, Goldberg MA, AntinJH, Rosenthal DS, Mayer RJ. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients. Blood 1988; 71: 690–6.
33. Tkachuk DC, Westbrook CA, Andreeff M, et al. Detection of bcr/abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science 1990; 250: 559–62.
34. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid receptor pathway. Nature 1990; 345: 224–9.
35. Miller WH Jr, Frankel SR, Warrell RP Jr, Dmitrovsky E. Molecular studies of retinoic acid receptors in patients with acute promyelocytic leukemia treated with all-trans retinoic acid. Clin Res (in press).
36. Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature 1987; 329: 219–22.
37. Pratt MAC, Kralova J, McBurney MW. A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol Cell Biol 1990; 10: 6445–53.
38. Flynn PJ, Miller WJ, Weisdorf DJ, Arthur DC, Brunning R, Branda RF. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood 1983; 62: 1211–7.
39. Nilsson B. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia. Br J Haematol 1984; 57: 365–71.
40. Daenen S, Vellenga E, van Dobbenburgh OA, Halie MR. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia. Blood 1986; 67: 559–61.
41. Fontana JA, Rogers JS II, Durham JP. The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia. Cancer 1986; 57: 209–17.
42. Wijermans PW, Rebel VI, Ossenkoppele GJ, Huijgens PC, Langenhuijsen MMAC. Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiation. Blood 1989; 73: 800–5.
43. Lichtman MA, Rowe JM. Hyperleukocytosis leukemias: rheological, clinical, and therapeutic considerations. Blood 1982; 60: 279–83.
44. Tobler A, Dawson MI, Koeffler HP. Retinoids: structure-function relationship in normal and leukemic hematopoiesis in vitro. J Clin Invest 1986; 78: 303–9.
45. Douer D, Koeffler HP. Retinoic acid enhances colony-stimulating factorinduced growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 1982; 138: 193–8.
46. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL60) by retinoic acid. Proc Natl Acad Sci U S A 1980; 77: 2936–40.
47. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795–801.
48. Kessler JF, Meyskens FL Jr, Levine N, Lynch PJ, Jones SE. Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet 1983; 1: 1345–7.